To investigate Egr-1 and Foxp3 manifestation in CD4+ T cells from MS patients, we segregated CD4+ T cells from the peripheral blood mononuclear cells (PBMCs) of treatment-naïve MS patients. This evidence concerns the gene EGR1 and myeloid sarcoma.